KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · IEX Real-Time Price · USD

11.51

-0.38 (-3.20%)

At close: Jul 2, 2024, 4:00 PM

11.55

+0.04 (0.35%)

After-hours: Jul 2, 2024, 5:06 PM EDT

KalVista Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-92.91	-82.34	-46.24	-29.12	-20.82	Upgrade
Depreciation & Amortization	0.8	0.74	0.65	0.53	0.38	Upgrade
Share-Based Compensation	9.92	11.09	7.12	4.45	2.97	Upgrade
Other Operating Activities	6.92	-7.62	8.3	-20.67	-18.89	Upgrade
Operating Cash Flow	-75.26	-78.13	-30.17	-44.82	-36.37	Upgrade
Capital Expenditures	-1.2	-0.93	-0.08	-0.22	-1.08	Upgrade
Change in Investments	42.61	58.79	-147.57	16.97	-68.34	Upgrade
Investing Cash Flow	41.42	57.86	-147.65	16.75	-69.42	Upgrade
Share Issuance / Repurchase	57.03	1.58	212.12	11.64	88.15	Upgrade
Debt Issued / Paid	0	0	0	-0.05	-0.21	Upgrade
Other Financing Activities	1.09	-	-	-	-	Upgrade
Financing Cash Flow	58.12	1.58	212.12	11.58	87.94	Upgrade
Exchange Rate Effect	1.24	-1.17	0.51	0.26	-1.21	Upgrade
Net Cash Flow	25.51	-19.86	34.8	-16.22	-19.05	Upgrade
Free Cash Flow	-76.46	-79.07	-30.25	-45.04	-37.45	Upgrade
Free Cash Flow Margin	-	-	-	-354.89%	-232.19%	Upgrade
Free Cash Flow Per Share	-2.74	-3.23	-1.58	-2.54	-2.48	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).